C

Cellectis

Develops allogeneic CAR-T cell therapies

Director – Clinical Quality Assurance

Regulatory & Quality (Life Sciences)Confirmed live in the last 24 hours
Full-timeNo salary listedIn-person

About the Job

Requirements

  • A bachelor's or master's degree in science, preferably in a Life Science, and at least 12 years of relevant GCP, pharmacovigilance, and quality assurance experience in a biopharmaceutical company.
  • At least 8 years of direct supervisory experience.
  • Extensive clinical trial experience in biological therapies and oncology, ideally in CAR-T therapies and hemato-oncology.
  • Experience supporting IND, CTA, and BLA/MAA or other regulatory submissions.
  • Ability to identify critical program risks and develop strategic or tactical plans to mitigate risks and costs.
  • Knowledge and understanding of regulations regarding cell and gene therapies, including ICH guidelines, GCP, and GMP as defined by the US Food and Drug Administration and European Medicines Agency.
  • Comprehensive knowledge of cell and gene therapy, GxPs, and their underlying theories and general principles.
  • Comprehensive knowledge of worldwide GCP compliance regulations.
  • Strong project management skills.
  • Ability to lead, motivate, and influence strategic direction, and to leverage and develop diverse perspectives and ideas from matrix teams.
  • Ability to independently lead initiatives, assess complex challenges, and implement practical solutions.
  • Strong written and verbal communication skills.
  • Ability to set and manage priorities and schedule activities accordingly, with strong analytical and problem-solving skills.
  • Interpersonal skills to work effectively with subordinates, peers, managers, and cross-functional teams.
  • Organizational skills with attention to detail and deadlines.
  • Team orientation, including the ability to coach and mentor.

Responsibilities

  • Define and execute the Clinical QA strategy throughout the development trajectory, including early-phase and late-stage clinical development.
  • Oversee GCP compliance for all clinical activities, including monitoring, data management, and pharmacovigilance.
  • Develop and implement inspection-readiness plans and procedures to ensure clinical studies and related activities are ready for Health Authority inspections.
  • Direct risk-based quality planning and continuous-improvement initiatives across clinical programs.
  • Manage vendor qualifications, audits, and corrective and preventive actions (CAPAs).
  • Collaborate cross-functionally to integrate quality principles into clinical development and regulatory deliverables.
  • Provide training and guidance to cross-functional teams on GCP regulations, Quality Assurance procedures, and audit protocols.
  • Develop quality strategies and priorities for short- and long-term objectives for the QA organization.
  • Work with internal stakeholders to ensure risk-based quality management is applied as appropriate to specific studies.
  • Facilitate review of potential Serious Breach and Urgent Safety Measure assessments arising from clinical programs.
  • Plan, coordinate, review, and approve clinical audits using a risk-informed strategy to ensure compliance in clinical studies and pharmacovigilance operations.
  • Implement and run internal GCP audit and training programs.
  • Serve as a subject matter expert on GCP quality assurance matters.
  • Develop KPIs to track and trend key Quality Indicators, and ensure adverse trends or patterns are noted and promptly addressed.
  • Travel up to 10% of the time.
  • Perform other responsibilities and duties assigned by the Company.

Desired Qualifications

  • Bilingual proficiency in French and English.

About the Company

Cellectis

Develops allogeneic CAR-T cell therapies

Cellectis develops immunotherapy treatments for cancer using gene-edited allogeneic CAR T cells. Its products rely on donor-derived T cells that are edited to remove T cell receptor activity and engineered to express a chimeric antigen receptor (CAR) that targets cancer cells. The goal is to create off-the-shelf CAR T therapies that are available quickly and at a lower cost than patient-specific (autologous) CAR T treatments. Cellectis works through research and development, clinical trials, and partnerships with other pharma companies, such as Sanofi, and generates revenue from licensing, milestone payments, and potential future product sales. The company differentiates itself by offering off-the-shelf solutions rather than custom-made therapies, aiming to broaden access to advanced cancer treatment.

Company size
201-500
Company stage
IPO
Headquarters
Paris, France
Founded
2000

Recently Posted Jobs

Explore more opportunities at Cellectis

See more jobs